Discovery shows how to treat heart attacks; drug development underway

Soleno Therapeutics announces Collaboration with Vanderbilt University to Discover and Develop Next Generation K (ATP) Channel Activators for the Treatment of Rare Diseases.

Appello Pharma completes Series A to advance treatment of Parkinson's